| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 621 | 2015 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ... The Lancet Neurology 20 (9), 762-772, 2021 | 343 | 2021 |
| A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder SH Kim, SY Huh, SJ Lee, AR Joung, HJ Kim JAMA neurology 70 (9), 1110-1117, 2013 | 330 | 2013 |
| Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years SH Kim, W Kim, XF Li, IJ Jung, HJ Kim Archives of neurology 68 (11), 1412-1420, 2011 | 318 | 2011 |
| Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity W Kim, MS Park, SH Lee, SH Kim, IJ Jung, T Takahashi, T Misu, ... Multiple Sclerosis Journal 16 (10), 1229-1236, 2010 | 215 | 2010 |
| Treatment outcomes with rituximab in 100 patients with neuromyelitis optica: influence of FCGR3A polymorphisms on the therapeutic response to rituximab SH Kim, IH Jeong, JW Hyun, AR Joung, HJ Jo, SH Hwang, S Yun, J Joo, ... JAMA neurology 72 (9), 989-995, 2015 | 200 | 2015 |
| Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? SH Kim, W Kim, XF Li, IJ Jung, HJ Kim Multiple Sclerosis Journal 18 (10), 1480-1483, 2012 | 199 | 2012 |
| Racial differences in neuromyelitis optica spectrum disorder SH Kim, MA Mealy, M Levy, F Schmidt, K Ruprecht, F Paul, M Ringelstein, ... Neurology 91 (22), e2089-e2099, 2018 | 158 | 2018 |
| Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels SH Kim, W Kim, SY Huh, KY Lee, IJ Jung, HJ Kim Journal of clinical neurology 9 (1), 36-42, 2013 | 156 | 2013 |
| Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases JW Hyun, MR Woodhall, SH Kim, IH Jeong, B Kong, G Kim, Y Kim, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (10), 811-817, 2017 | 154 | 2017 |
| Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder SY Huh, SH Kim, JW Hyun, AR Joung, MS Park, BJ Kim, HJ Kim JAMA neurology 71 (11), 1372-1378, 2014 | 140 | 2014 |
| Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica SH Kim, W Kim, MS Park, EH Sohn, XF Li, HJ Kim Archives of neurology 68 (4), 473-479, 2011 | 134 | 2011 |
| Influence of pregnancy on neuromyelitis optica spectrum disorder W Kim, SH Kim, I Nakashima, Y Takai, K Fujihara, MI Leite, J Kitley, ... Neurology 78 (16), 1264-1267, 2012 | 131 | 2012 |
| Leptomeningeal metastasis: clinical experience of 519 cases JW Hyun, IH Jeong, AR Joung, HJ Cho, SH Kim, HJ Kim European Journal of Cancer 56, 107-114, 2016 | 130 | 2016 |
| Clinical spectrum of CNS aquaporin-4 autoimmunity SH Kim, W Kim, XF Li, IJ Jung, HJ Kim Neurology 78 (15), 1179-1185, 2012 | 125 | 2012 |
| Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints IH Jeong, B Park, SH Kim, JW Hyun, J Joo, HJ Kim Multiple Sclerosis Journal 22 (3), 329-339, 2016 | 115 | 2016 |
| Brain abnormalities in neuromyelitis optica spectrum disorder W Kim, SH Kim, SY Huh, HJ Kim Multiple sclerosis international 2012 (1), 735486, 2012 | 104 | 2012 |
| The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders SY Huh, JH Min, W Kim, SH Kim, HJ Kim, BJ Kim, BJ Kim, KH Lee Multiple Sclerosis Journal 20 (6), 695-704, 2014 | 99 | 2014 |
| So you want to image myelin using MRI: an overview and practical guide for myelin water imaging J Lee, JW Hyun, J Lee, EJ Choi, HG Shin, K Min, Y Nam, HJ Kim, SH Oh Journal of Magnetic Resonance Imaging 53 (2), 360-373, 2021 | 98 | 2021 |
| Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker O Aktas, MA Smith, WA Rees, JL Bennett, D She, E Katz, BAC Cree, ... Annals of neurology 89 (5), 895-910, 2021 | 97 | 2021 |
Yeseul KimUniversity of Pennsylvania在 pennmedicine.upenn.edu 的电子邮件经过验证
